Compound adsorption device in pathogen reduction technology removes multiple drugs from plasma components
The INTERCEPT PRT plasma kit CAD effectively removed multiple drug classes, suggesting a potential role in mitigating drug contamination in transfusable plasma products. These findings may support the reconsideration of some medication-based donor deferrals where the risk-benefit of donor safety and product efficacy favors collection.
Authors
- Waseem Q. Anani (ORCID: https://orcid.org/0000-0003-2715-642X)
- B. Greenwall
- K. Reeder
Institutions
- University of Utah (US)
- ARUP Laboratories (United States) (US)
Publication Details
- Journal
- Transfusion
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1111/trf.18485
- Primary Topic
- Blood donation and transfusion practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Partenariat Canadien Contre Le Cancer
- National Institutes of Health
- Center for AIDS Research, University of Washington
- University of North Carolina at Chapel Hill